|
US4873192A
(en)
|
1987-02-17 |
1989-10-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Process for site specific mutagenesis without phenotypic selection
|
|
JPH07502653A
(ja)
|
1991-12-23 |
1995-03-23 |
カイロン コーポレイション |
溶液相サンドイッチハイブリダイゼーションアッセイに用いるためのｈｂｖ増幅プローブ
|
|
EP1288296A3
(en)
*
|
1992-05-11 |
2003-03-12 |
Ribozyme Pharmaceuticals, Inc. |
Method and reagent for inhibiting HBV viral replication
|
|
US6015832A
(en)
|
1997-12-31 |
2000-01-18 |
The Regents Of The University Of Michigan |
Methods of inactivating bacteria including bacterial spores
|
|
US6635676B2
(en)
|
1999-04-28 |
2003-10-21 |
Regents Of The University Of Michigan |
Non-toxic antimicrobial compositions and methods of use
|
|
US6559189B2
(en)
|
1999-04-28 |
2003-05-06 |
Regents Of The University Of Michigan |
Non-toxic antimicrobial compositions and methods of use
|
|
US7767216B2
(en)
|
1999-04-28 |
2010-08-03 |
The Regents Of The University Of Michigan |
Antimicrobial compositions and methods of use
|
|
US6506803B1
(en)
|
1999-04-28 |
2003-01-14 |
Regents Of The University Of Michigan |
Methods of preventing and treating microbial infections
|
|
US6555674B2
(en)
|
2000-08-09 |
2003-04-29 |
Nsgene A/S |
JeT promoter
|
|
CN1204248C
(zh)
*
|
2002-02-05 |
2005-06-01 |
中国人民解放军第四军医大学 |
治疗乙肝病毒感染的靶向核糖核酸酶的制备工艺
|
|
US7074596B2
(en)
|
2002-03-25 |
2006-07-11 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Synthesis and use of anti-reverse mRNA cap analogues
|
|
US7404969B2
(en)
|
2005-02-14 |
2008-07-29 |
Sirna Therapeutics, Inc. |
Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
|
|
TWI382019B
(zh)
|
2005-08-19 |
2013-01-11 |
Array Biopharma Inc |
作為類鐸受體（ｔｏｌｌ-ｌｉｋｅ ｒｅｃｅｐｔｏｒ）調節劑之胺基二氮雜呯
|
|
TWI404537B
(zh)
|
2005-08-19 |
2013-08-11 |
Array Biopharma Inc |
作為類鐸受體（ｔｏｌｌ-ｌｉｋｅ ｒｅｃｅｐｔｏｒ）調節劑之８-經取代苯并氮雜呯
|
|
EP4174179B1
(en)
|
2005-08-23 |
2025-05-07 |
The Trustees of the University of Pennsylvania |
Rna containing modified nucleosides and methods of use thereof
|
|
ES2533370T3
(es)
*
|
2005-10-18 |
2015-04-09 |
Precision Biosciences |
Meganucleasas diseñadas racionalmente con especificidad de secuencia y afinidad de unión a ADN alteradas
|
|
JP4235837B2
(ja)
|
2006-04-04 |
2009-03-11 |
セイコーエプソン株式会社 |
粒状性の予測、プロファイルの作成および印刷装置
|
|
US8338593B2
(en)
|
2006-07-07 |
2012-12-25 |
Gilead Sciences, Inc. |
Modulators of toll-like receptor 7
|
|
WO2009001159A1
(en)
|
2007-06-25 |
2008-12-31 |
Cellectis |
Method for enhancing the cleavage activity of i-crei derived meganucleases
|
|
US8748373B2
(en)
*
|
2007-02-21 |
2014-06-10 |
Fox Chase Cancer Center |
Hepatitis B virus compositions and methods of use
|
|
JP5395068B2
(ja)
|
2007-06-29 |
2014-01-22 |
ギリアード サイエンシーズ， インコーポレイテッド |
トール様受容体７の調節物質としてのプリン誘導体およびその使用
|
|
EP2660317B1
(en)
|
2007-10-31 |
2016-04-06 |
Precision Biosciences, Inc. |
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
|
|
EP3100718B1
(en)
|
2008-01-02 |
2019-11-27 |
Arbutus Biopharma Corporation |
Improved compositions and methods for the delivery of nucleic acids
|
|
CN104042611B
(zh)
|
2008-07-08 |
2019-05-14 |
因塞特控股公司 |
作为吲哚胺2，3-双加氧酶的抑制剂的1，2，5-噁二唑
|
|
PT2313111E
(pt)
|
2008-08-01 |
2013-12-05 |
Ventirx Pharmaceuticals Inc |
Formulações de agonista de receptor do tipo toll e seus usos
|
|
CN103497192B
(zh)
|
2008-12-09 |
2015-09-23 |
吉里德科学公司 |
Toll样受体调节剂
|
|
WO2010136841A2
(en)
*
|
2009-05-26 |
2010-12-02 |
Cellectis |
Meganuclease variants cleaving the genome of a non-genomically integrating virus and uses thereof
|
|
US20120171191A1
(en)
|
2009-05-26 |
2012-07-05 |
Cellectis |
Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof
|
|
DK2467377T3
(en)
|
2009-08-18 |
2017-04-03 |
Ventirx Pharmaceuticals Inc |
SUBSTITUTED BENZOAZEPINS AS MODULATORS OF TOLL-LIKE RECEPTORS
|
|
CN105669552A
(zh)
|
2009-08-18 |
2016-06-15 |
文蒂雷克斯药品公司 |
作为toll样受体调节剂的取代的苯并氮杂*
|
|
SI2491035T1
(sl)
|
2009-10-22 |
2017-10-30 |
Gilead Sciences, Inc. |
Derivati purina ali deazapurina uporabni za zdravljenje (med drugimi) virusnih okužb
|
|
WO2011106573A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
|
|
KR101537148B1
(ko)
|
2010-05-31 |
2015-07-15 |
오노 야꾸힝 고교 가부시키가이샤 |
푸리논 유도체
|
|
US8907053B2
(en)
|
2010-06-25 |
2014-12-09 |
Aurigene Discovery Technologies Limited |
Immunosuppression modulating compounds
|
|
US20120082658A1
(en)
|
2010-10-01 |
2012-04-05 |
Ventirx Pharmaceuticals, Inc. |
Methods for the Treatment of Allergic Diseases
|
|
SG189071A1
(en)
|
2010-10-01 |
2013-05-31 |
Ventirx Pharmaceuticals Inc |
Therapeutic use of a tlr agonist and combination therapy
|
|
AR084217A1
(es)
|
2010-12-10 |
2013-05-02 |
Gilead Sciences Inc |
Inhibidores macrociclicos de virus flaviviridae
|
|
MX348935B
(es)
|
2011-01-12 |
2017-07-03 |
Ventirx Pharmaceuticals Inc |
Benzoazepinas sustituidas como moduladores de receptores tipo toll.
|
|
EP3208263A1
(en)
|
2011-01-12 |
2017-08-23 |
VentiRx Pharmaceuticals, Inc. |
Substituted benzoazepines as toll-like receptor modulators
|
|
CN103476426B
(zh)
|
2011-02-12 |
2021-08-10 |
全球免疫股份有限公司 |
用于慢性乙型肝炎病毒感染的基于酵母的治疗剂
|
|
TR201815062T4
(tr)
|
2011-04-08 |
2018-11-21 |
Janssen Sciences Ireland Uc |
Viral enfeksiyonların tedavisine yönelik pirimidin deriveleri.
|
|
SMT201800152T1
(it)
|
2011-05-18 |
2018-05-02 |
Janssen Sciences Ireland Uc |
Derivati della chinazolina per il trattamento di infezioni virali e ulteriori malattie
|
|
DK3489366T3
(da)
|
2011-06-01 |
2020-02-24 |
Prec Biosciences Inc |
Fremgangsmåder og produkter til produktion af manipulerede mammale cellelinier med forstærkede transgener
|
|
WO2012168944A1
(en)
|
2011-06-08 |
2012-12-13 |
Aurigene Discovery Technologies Limited |
Therapeutic compounds for immunomodulation
|
|
WO2013003520A1
(en)
*
|
2011-06-30 |
2013-01-03 |
Arrowhead Research Corporation |
Compositions and methods for inhibiting gene expression of hepatitis b virus
|
|
WO2013006841A1
(en)
*
|
2011-07-06 |
2013-01-10 |
Yale University |
Stimulation of arterial collateral growth and lymphogenesis
|
|
MX353548B
(es)
|
2011-11-29 |
2018-01-18 |
Ono Pharmaceutical Co |
Clorhidrato derivado de purinona.
|
|
KR20190007106A
(ko)
|
2011-12-21 |
2019-01-21 |
노비라 테라퓨틱스, 인코포레이티드 |
B형 간염의 항바이러스성 제제
|
|
EP2812331B1
(en)
|
2012-02-08 |
2019-01-02 |
Janssen Sciences Ireland Unlimited Company |
Piperidino-pyrimidine derivatives for the treatment of viral infections
|
|
WO2013132317A1
(en)
|
2012-03-07 |
2013-09-12 |
Aurigene Discovery Technologies Limited |
Peptidomimetic compounds as immunomodulators
|
|
MX2014011353A
(es)
|
2012-03-29 |
2014-12-05 |
Aurigene Discovery Tech Ltd |
Inmunomodulacion de compuestos ciclicos del bucle bc de muerte celular programada (pd1) humana.
|
|
WO2013144129A1
(en)
|
2012-03-31 |
2013-10-03 |
F. Hoffmann-La Roche Ag |
Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
|
US20130267517A1
(en)
|
2012-03-31 |
2013-10-10 |
Hoffmann-La Roche Inc. |
Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
|
WO2013159109A1
(en)
|
2012-04-20 |
2013-10-24 |
Isis Pharmaceuticals, Inc. |
Modulation of hepatitis b virus (hbv) expression
|
|
EA037351B8
(ru)
|
2012-05-15 |
2021-04-29 |
Бристол-Майерс Сквибб Компани |
Способ лечения злокачественных опухолей с использованием комбинации антител против pd-1 и ctla-4
|
|
HK1211285A1
(en)
|
2012-06-08 |
2016-05-20 |
吉利德科学公司 |
Macrocyclic inhibitors of flaviviridae viruses
|
|
PL2859009T3
(pl)
|
2012-06-08 |
2018-03-30 |
Gilead Sciences, Inc. |
Makrocykliczne inhibitory wirusów flaviviridae
|
|
AR091279A1
(es)
|
2012-06-08 |
2015-01-21 |
Gilead Sciences Inc |
Inhibidores macrociclicos de virus flaviviridae
|
|
UA115558C2
(uk)
|
2012-08-10 |
2017-11-27 |
ЯНССЕН САЙЄНСЕС АЙРЛЕНД ЮСі |
Алкілпіримідинові похідні для лікування вірусних інфекцій та подальших захворювань
|
|
KR102271574B1
(ko)
|
2012-08-28 |
2021-07-01 |
얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 |
설파모일-아릴아미드 및 b형 간염 치료제로서의 그 용도
|
|
ES2610758T3
(es)
|
2012-08-28 |
2017-05-03 |
Janssen Sciences Ireland Uc |
Derivados de sulfamoílo bicíclicos condensados y su uso como medicamentos en el tratamiento de la hepatitis B
|
|
WO2014037480A1
(en)
|
2012-09-10 |
2014-03-13 |
F. Hoffmann-La Roche Ag |
6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
|
RS55764B1
(sr)
|
2012-10-02 |
2017-07-31 |
Gilead Sciences |
Inhibitori histonskih demetilaza
|
|
MX386924B
(es)
|
2012-10-10 |
2025-03-19 |
Janssen Sciences Ireland Uc |
Derivados pirrolo[3,2-d]pirimidínicos para el tratamiento de infecciones víricas y otras enfermedades.
|
|
EA035431B1
(ru)
|
2012-11-16 |
2020-06-15 |
Янссен Сайенсиз Айрлэнд Юси |
Гетероциклические замещенные производные 2-амино-хиназолина в качестве модуляторов tlr7 и/или tlr8 для лечения вирусных инфекций
|
|
US8987461B2
(en)
|
2012-12-06 |
2015-03-24 |
Quanticel Pharmaceuticals, Inc. |
Histone demethylase inhibitors
|
|
AU2013361255B2
(en)
|
2012-12-19 |
2017-01-05 |
Celgene Quanticel Research, Inc. |
Histone demethylase inhibitors
|
|
AU2013363957B2
(en)
|
2012-12-21 |
2018-03-22 |
Celgene Quanticel Research, Inc. |
Histone demethylase inhibitors
|
|
SG11201506639XA
(en)
|
2013-02-21 |
2015-09-29 |
Janssen Sciences Ireland Uc |
2-aminopyrimidine derivatives for the treatment of viral infections
|
|
JP6514117B2
(ja)
|
2013-02-27 |
2019-05-15 |
エピセラピューティクス アーペーエス |
ヒストン脱メチル化酵素の阻害剤
|
|
SI2961732T1
(sl)
|
2013-02-28 |
2017-07-31 |
Janssen Sciences Ireland Uc |
Sulfamoil-arilamidi in njihova uporaba kot zdravila za zdravljenje hepatitisa B
|
|
JP6320506B2
(ja)
|
2013-03-12 |
2018-05-09 |
セルジーン クオンティセル リサーチ，インク． |
ヒストンデメチラーゼ阻害剤
|
|
WO2014165128A2
(en)
|
2013-03-12 |
2014-10-09 |
Novira Therapeutics, Inc. |
Hepatitis b antiviral agents
|
|
CN105980386B
(zh)
|
2013-03-13 |
2021-08-13 |
基因泰克公司 |
吡唑并化合物及其用途
|
|
EP2969007B1
(en)
|
2013-03-14 |
2019-05-08 |
Celgene Quanticel Research, Inc. |
Histone demethylase inhibitors
|
|
HUE034906T2
(hu)
|
2013-03-15 |
2018-03-28 |
Quanticel Pharmaceuticals Inc |
Hiszton-demetiláz inhibitorok
|
|
US9308236B2
(en)
|
2013-03-15 |
2016-04-12 |
Bristol-Myers Squibb Company |
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
|
|
PT2981536T
(pt)
|
2013-04-03 |
2017-08-09 |
Janssen Sciences Ireland Uc |
Derivados de n-fenil-carboxamida e sua utilização como medicamentos para o tratamento da hepatite b
|
|
CN105377867B
(zh)
|
2013-05-03 |
2019-11-12 |
加利福尼亚大学董事会 |
I型干扰素的环状二核苷酸诱导
|
|
JO3603B1
(ar)
|
2013-05-17 |
2020-07-05 |
Janssen Sciences Ireland Uc |
مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي
|
|
US10160743B2
(en)
|
2013-05-17 |
2018-12-25 |
Janssen Sciences Ireland Uc |
Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
|
|
PE20151951A1
(es)
|
2013-05-17 |
2015-12-26 |
Hoffmann La Roche |
Heteroarildihidropirimidinas unidas por puentes en 6 para el tratamiento y la profilaxis de infeccion por el virus de la hepatitis b
|
|
SG11201600522UA
(en)
|
2013-07-25 |
2016-02-26 |
Janssen Sciences Ireland Uc |
Glyoxamide substituted pyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
|
|
CN105492446B
(zh)
|
2013-07-30 |
2018-08-03 |
爱尔兰詹森科学公司 |
用于治疗病毒性感染的噻吩并[3,2-d]嘧啶衍生物
|
|
WO2015019284A2
(en)
|
2013-08-05 |
2015-02-12 |
Cambridge Enterprise Limited |
Inhibition of cxcr4 signaling in cancer immunotherapy
|
|
US10471139B2
(en)
|
2013-08-15 |
2019-11-12 |
The University Of Kansas |
Toll-like receptor agonists
|
|
CA2923184A1
(en)
|
2013-09-04 |
2015-03-12 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
|
HUE048874T2
(hu)
|
2013-09-06 |
2020-08-28 |
Aurigene Discovery Tech Ltd |
1,2,4-oxadiazol-származékok, mint immunmodulátorok
|
|
HUE039012T2
(hu)
|
2013-09-06 |
2018-12-28 |
Aurigene Discovery Tech Ltd |
Gyûrûs peptidomimetikus vegyületek, mint immunomodulátorok
|
|
SMT201800421T1
(it)
|
2013-09-06 |
2018-09-13 |
Aurigene Discovery Tech Ltd |
Derivati di 1,3,4-ossadiazolo e 1,3,4-tiadiazolo come immunomodulatori
|
|
WO2015036927A1
(en)
|
2013-09-10 |
2015-03-19 |
Aurigene Discovery Technologies Limited |
Immunomodulating peptidomimetic derivatives
|
|
HRP20201953T1
(hr)
|
2013-09-11 |
2021-04-30 |
Institut National De La Santé Et De La Recherche Médicale (Inserm) |
Postupci i farmaceutski pripravci za liječenje virusne infekcije hepatitisom b
|
|
WO2015044900A1
(en)
|
2013-09-27 |
2015-04-02 |
Aurigene Discovery Technologies Limited |
Therapeutic immunomodulating compounds
|
|
US9663486B2
(en)
|
2013-10-14 |
2017-05-30 |
Eisai R&D Management Co., Ltd. |
Selectively substituted quinoline compounds
|
|
EP3626717A1
(en)
|
2013-10-14 |
2020-03-25 |
Eisai R&D Management Co., Ltd. |
Selectively substituted quinoline compounds
|
|
NZ717629A
(en)
|
2013-10-23 |
2021-12-24 |
Janssen Sciences Ireland Uc |
Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
|
|
CN106255684B
(zh)
|
2013-11-14 |
2019-08-23 |
诺维拉治疗公司 |
氮杂环庚烷衍生物和治疗乙型肝炎感染的方法
|
|
MX374530B
(es)
*
|
2013-12-12 |
2025-03-06 |
Broad Inst Inc |
Suministro, uso y aplicaciones terapeuticas de los sistemas y composiciones crispr-cas para actuar sobre hbv y trastornos y enfermedades virales.
|
|
CA2933466A1
(en)
|
2013-12-13 |
2015-06-18 |
Takeda Pharmaceutical Company Limited |
Pyrrolo[3,2-c]pyridine derivatives as tlr inhibitors
|
|
US10654807B2
(en)
|
2013-12-20 |
2020-05-19 |
The University Of Kansas |
Toll-like receptor 8 agonists
|
|
US9181288B2
(en)
|
2014-01-16 |
2015-11-10 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
|
US9169212B2
(en)
|
2014-01-16 |
2015-10-27 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
|
CA2931329A1
(en)
|
2014-01-30 |
2015-08-06 |
F. Hoffmann-La Roche Ag |
Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection
|
|
SG11201606428UA
(en)
|
2014-02-04 |
2016-09-29 |
Incyte Corp |
Combination of a pd-1 antagonist and an ido1 inhibitor for treating cancer
|
|
CN110483484A
(zh)
|
2014-02-06 |
2019-11-22 |
爱尔兰詹森科学公司 |
氨磺酰基吡咯酰胺衍生物及其作为药物用于治疗乙型肝炎的用途
|
|
US20170088626A1
(en)
|
2014-03-05 |
2017-03-30 |
Bristol-Myers Squibb Company |
Treatment of renal cancer using a combination of an anti-pd-1 antibody and another anti-cancer agent
|
|
RS58384B1
(sr)
|
2014-03-07 |
2019-04-30 |
Hoffmann La Roche |
Novi 6-fuzionisani heteroarildihidropirimidini za lečenje i profilaksu infekcije virusom hepatitisa b
|
|
US9400280B2
(en)
|
2014-03-27 |
2016-07-26 |
Novira Therapeutics, Inc. |
Piperidine derivatives and methods of treating hepatitis B infections
|
|
US9850225B2
(en)
|
2014-04-14 |
2017-12-26 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
|
CA2938280C
(en)
|
2014-04-22 |
2022-07-12 |
F. Hoffmann-La Roche Ag |
4-amino-imidazoquinoline compounds
|
|
ES2908150T3
(es)
|
2014-05-01 |
2022-04-27 |
Novartis Ag |
Compuestos y composiciones como agonistas del receptor de tipo Toll 7
|
|
EA030603B1
(ru)
|
2014-05-01 |
2018-08-31 |
Новартис Аг |
СОЕДИНЕНИЯ И КОМПОЗИЦИИ В КАЧЕСТВЕ АГОНИСТОВ Toll-ПОДОБНОГО РЕЦЕПТОРА 7
|
|
KR20160148715A
(ko)
|
2014-05-13 |
2016-12-26 |
에프. 호프만-라 로슈 아게 |
B형 간염 바이러스 감염의 치료 또는 예방을 위한 신규한 다이하이드로퀴놀리진온
|
|
WO2015179615A1
(en)
|
2014-05-23 |
2015-11-26 |
Eisai R&D Management Co., Ltd |
Combination therapies for the treatment of cancer
|
|
US10066241B2
(en)
|
2014-05-30 |
2018-09-04 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods of delivering treatments for latent viral infections
|
|
EP3151820A4
(en)
|
2014-06-06 |
2017-11-22 |
Flexus Biosciences, Inc. |
Immunoregulatory agents
|
|
WO2016012470A1
(en)
|
2014-07-25 |
2016-01-28 |
F. Hoffmann-La Roche Ag |
New amorphous and crystalline forms of (3s)-4-[[(4r)-4-(2-chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1, 4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic acid
|
|
US9980956B2
(en)
|
2014-08-01 |
2018-05-29 |
3M Innovative Properties Company |
Methods and therapeutic combinations for treating tumors
|
|
EP3180319B1
(en)
|
2014-08-14 |
2018-10-03 |
F.Hoffmann-La Roche Ag |
Novel pyridazones and triazinones for the treatment and prophylaxis of hepatitis b virus infection
|
|
EA032824B1
(ru)
|
2014-08-15 |
2019-07-31 |
Чиа Тай Тяньцин Фармасьютикал Груп Ко., Лтд. |
Пирролопиримидиновые соединения, используемые в качестве агониста tlr7
|
|
EP3183251A4
(en)
|
2014-08-22 |
2017-12-27 |
Janus Biotherapeutics, Inc. |
Novel n2, n4, n7, 6-tetrasubstituted pteridine-2,4,7-triamine and 2, 4, 6, 7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof
|
|
JP2017526675A
(ja)
|
2014-08-27 |
2017-09-14 |
ギリアード サイエンシーズ， インコーポレイテッド |
ヒストンデメチラーゼを阻害するための化合物および方法
|
|
US9884866B2
(en)
|
2014-09-08 |
2018-02-06 |
Regents Of The University Of Minnesota |
Immunomodulators and immunomodulator conjugates
|
|
WO2016039749A1
(en)
|
2014-09-11 |
2016-03-17 |
Bristol-Myers Squibb Company |
Macrocyclic inhibitors of the pd-1/pd-l1 and cd80 (b7-1)/pd-li protein/protein interactions
|
|
JP6783230B2
(ja)
|
2014-10-10 |
2020-11-11 |
ジェネンテック， インコーポレイテッド |
ヒストンデメチラーゼのインヒビターとしてのピロリドンアミド化合物
|
|
US9732119B2
(en)
|
2014-10-10 |
2017-08-15 |
Bristol-Myers Squibb Company |
Immunomodulators
|
|
WO2016055553A1
(en)
|
2014-10-11 |
2016-04-14 |
F. Hoffmann-La Roche Ag |
Compounds for use in the treatment of infectious diseases
|
|
US9637485B2
(en)
|
2014-11-03 |
2017-05-02 |
Hoffmann-La Roche Inc. |
6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection
|
|
MX2017005462A
(es)
|
2014-11-05 |
2017-07-28 |
Flexus Biosciences Inc |
Agentes inmunorreguladores.
|
|
UY36390A
(es)
|
2014-11-05 |
2016-06-01 |
Flexus Biosciences Inc |
Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen
|
|
US10584125B2
(en)
|
2014-11-13 |
2020-03-10 |
Glaxosmithkline Biologicals Sa |
Adenine derivatives which are useful in the treatment of allergic diseases or other inflammatory conditions
|
|
US9856292B2
(en)
|
2014-11-14 |
2018-01-02 |
Bristol-Myers Squibb Company |
Immunomodulators
|
|
KR102557560B1
(ko)
|
2014-12-08 |
2023-07-20 |
에프. 호프만-라 로슈 아게 |
바이러스 감염의 치료 또는 예방을 위한 3-치환된 5-아미노-6H-티아졸로[4,5-d]피리미딘-2,7-다이온 화합물
|
|
WO2016096778A1
(en)
|
2014-12-18 |
2016-06-23 |
F. Hoffmann-La Roche Ag |
Benzazepine sulfonamide compounds
|
|
US9861680B2
(en)
|
2014-12-18 |
2018-01-09 |
Bristol-Myers Squibb Company |
Immunomodulators
|
|
US9944678B2
(en)
|
2014-12-19 |
2018-04-17 |
Bristol-Myers Squibb Company |
Immunomodulators
|
|
AR103222A1
(es)
|
2014-12-23 |
2017-04-26 |
Hoffmann La Roche |
Procedimiento para la preparación de análogos de 4-fenil-5-alcoxicarbonil-2-tiazol-2-il-1,4-dihidropirimidina
|
|
US9676793B2
(en)
|
2014-12-23 |
2017-06-13 |
Hoffmann-Laroche Inc. |
Co-crystals of 5-amino-2-oxothiazolo[4,5-d]pyrimidin-3(2H)-yl-5-hydroxymethyl tetrahydrofuran-3-yl acetate and methods for preparing and using the same
|
|
CN105732635A
(zh)
|
2014-12-29 |
2016-07-06 |
南京明德新药研发股份有限公司 |
一类Toll样受体7激动剂
|
|
JP6506845B2
(ja)
|
2014-12-30 |
2019-04-24 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
Ｂ型肝炎ウイルス感染症の治療及び予防のための新規テトラヒドロピリドピリミジン類及びテトラヒドロピリドピリジン類
|
|
JP6713465B2
(ja)
|
2014-12-30 |
2020-06-24 |
ノヴィラ・セラピューティクス・インコーポレイテッド |
Ｂ型肝炎感染症治療のための誘導体及び方法
|
|
WO2016107833A1
(en)
|
2014-12-31 |
2016-07-07 |
F. Hoffmann-La Roche Ag |
A novel high-throughput method for quantification of hbv cccdna from cell lysate by real-time pcr
|
|
MA41338B1
(fr)
|
2015-01-16 |
2019-07-31 |
Hoffmann La Roche |
Composés de pyrazine pour le traitement de maladies infectieuses
|
|
EP3250685A1
(en)
|
2015-01-27 |
2017-12-06 |
F. Hoffmann-La Roche AG |
Recombinant hbv cccdna, the method to generate thereof and the use thereof
|
|
US20160222060A1
(en)
|
2015-02-04 |
2016-08-04 |
Bristol-Myers Squibb Company |
Immunomodulators
|
|
HK1244281B
(zh)
|
2015-02-11 |
2020-02-07 |
F. Hoffmann-La Roche Ag |
治疗和预防乙型肝炎病毒感染的2-氧代-6，7-二氢苯并[a]喹嗪-3-甲酸衍生物
|
|
PH12021551982A1
(en)
|
2015-03-04 |
2022-09-05 |
Gilead Sciences Inc |
Toll-like receptor modulating 4,6-diamino-pyrido[3,2-d]pyrimidine compounds
|
|
RU2712248C2
(ru)
|
2015-03-06 |
2020-01-27 |
Ф. Хоффманн-Ля Рош Аг |
Соединения бензазепина дикарбоксамида
|
|
EP3267999A4
(en)
|
2015-03-10 |
2018-07-25 |
Aurigene Discovery Technologies Limited |
1,3,4-oxadiazole and thiadiazole compounds as immunomodulators
|
|
EA201791634A1
(ru)
|
2015-03-10 |
2018-03-30 |
Ауриджен Дискавери Текнолоджис Лимитед |
3-замещенные 1,3,4-оксадиазольные и тиадиазольные соединения в качестве иммуномодуляторов
|
|
EA201791628A1
(ru)
|
2015-03-10 |
2018-02-28 |
Ауриджен Дискавери Текнолоджис Лимитед |
Терапевтические циклические соединения в качестве иммуномодуляторов
|
|
CA2979161A1
(en)
|
2015-03-10 |
2016-09-15 |
Aurigene Discovery Technologies Limited |
3-substituted-1,2,4-oxadiazole and thiadiazole compounds as immunomodulators
|
|
AU2016230793B2
(en)
|
2015-03-10 |
2021-03-25 |
Aurigene Discovery Technologies Limited |
1,2,4-oxadiazole and thiadiazole compounds as immunomodulators
|
|
US9809625B2
(en)
|
2015-03-18 |
2017-11-07 |
Bristol-Myers Squibb Company |
Immunomodulators
|
|
US10442788B2
(en)
|
2015-04-01 |
2019-10-15 |
Enanta Pharmaceuticals, Inc. |
Hepatitis B antiviral agents
|
|
CN107922377A
(zh)
|
2015-04-17 |
2018-04-17 |
美国印第安纳大学研究和技术公司 |
乙肝病毒组装效应子
|
|
EP3292120B1
(en)
|
2015-05-04 |
2019-06-19 |
H. Hoffnabb-La Roche Ag |
Tetrahydropyridopyrimidines and tetrahydropyridopyridines as inhibitors of hbsag (hbv surface antigen) and hbv dna production for the treatment of hepatitis b virus infections
|
|
EP3294746B1
(en)
|
2015-05-12 |
2021-10-06 |
F. Hoffmann-La Roche AG |
Substituted aminothiazolopyrimidinedione derivatives for the treatment and prophylaxis of virus infection
|
|
WO2016195982A2
(en)
|
2015-06-01 |
2016-12-08 |
The Penn State Research Foundation |
Hepatitis b virus capsid assembly
|
|
GB201511477D0
(en)
|
2015-06-30 |
2015-08-12 |
Redx Pharma Plc |
Antiviral compounds
|
|
WO2017001307A1
(en)
|
2015-06-30 |
2017-01-05 |
F. Hoffmann-La Roche Ag |
Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection
|
|
US10875876B2
(en)
|
2015-07-02 |
2020-12-29 |
Janssen Sciences Ireland Uc |
Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
|
|
WO2017007701A1
(en)
|
2015-07-07 |
2017-01-12 |
Merck Sharp & Dohme Corp. |
Antiviral phosphodiamide compounds
|
|
JP6598974B2
(ja)
|
2015-07-21 |
2019-10-30 |
エフ．ホフマン−ラ ロシュ アーゲー |
Ｂ型肝炎ウイルス感染症の治療および予防のための新規な三環式４−ピリドン−３−カルボン酸誘導体
|
|
WO2017016960A1
(en)
|
2015-07-24 |
2017-02-02 |
F. Hoffmann-La Roche Ag |
Process for the preparation of (6s)-6-alkyl-10-alkoxy-9-(substituted alkoxy)-2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid analogues
|
|
JP6506880B2
(ja)
|
2015-07-27 |
2019-04-24 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
Ｂ型肝炎ウィルス感染症の治療および予防のための新規な四環式４−オキソ−ピリジン−３−カルボン酸誘導体
|
|
WO2017017043A1
(en)
|
2015-07-28 |
2017-02-02 |
F. Hoffmann-La Roche Ag |
Novel 6,7-dihydropyrido[2,1-a]phthalazin-2-ones for the treatment and prophylaxis of hepatitis b virus infection
|
|
RU2018105846A
(ru)
|
2015-07-29 |
2019-08-28 |
Новартис Аг |
Комбинация антагониста pd-1 с ингибитором egfr
|
|
HK1249107A1
(zh)
|
2015-08-10 |
2018-10-26 |
Merck Sharp & Dohme Corp. |
抗病毒β-氨基酸酯磷酸二酰胺化合物
|
|
JP6596146B2
(ja)
|
2015-08-13 |
2019-10-23 |
メルク・シャープ・アンド・ドーム・コーポレーション |
Ｓｔｉｎｇアゴニストとしての環状ジヌクレオチド化合物
|
|
EP3337481B1
(en)
|
2015-08-21 |
2020-11-11 |
The University of Kansas |
Quinoline-2-amine derivatives as human tlr8-selective agonists for increasing immune response
|
|
WO2017038909A1
(en)
|
2015-08-28 |
2017-03-09 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compounds
|
|
CA2996213C
(en)
|
2015-08-31 |
2023-10-03 |
3M Innovative Properties Company |
Guanidine substituted imidazo[4,5-c] ring compounds
|
|
TW201720802A
(zh)
|
2015-09-15 |
2017-06-16 |
艾森伯利生物科學公司 |
B型肝炎核心蛋白質調節劑
|
|
JP6893501B2
(ja)
|
2015-09-17 |
2021-06-23 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
スルフィニルフェニル又はスルホンイミドイルフェニルベンザゼピン
|
|
WO2017047769A1
(ja)
|
2015-09-17 |
2017-03-23 |
国立大学法人富山大学 |
トール様受容体７またはトール様受容体９の活性化阻害剤
|
|
EP3360554B1
(en)
|
2015-10-05 |
2021-07-28 |
FUJIFILM Toyama Chemical Co., Ltd. |
Anti-hepatitis b virus agent
|
|
CA3001283C
(en)
|
2015-10-07 |
2023-10-10 |
Sumitomo Dainippon Pharma Co., Ltd. |
Pyrimidine compound
|
|
US10745382B2
(en)
|
2015-10-15 |
2020-08-18 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
|
WO2017070089A1
(en)
|
2015-10-19 |
2017-04-27 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
CN108430503A
(zh)
|
2015-10-28 |
2018-08-21 |
艾杜罗生物科技公司 |
用于激活“干扰素基因刺激物”依赖性信号传导的组合物和方法
|
|
AU2016349501B2
(en)
|
2015-11-04 |
2022-07-21 |
Incyte Corporation |
Pharmaceutical compositions and methods for indoleamine 2,3-dioxygenase inhibition and indications therefor
|
|
SG11201803474UA
(en)
|
2015-11-04 |
2018-05-30 |
Hookipa Biotech Ag |
Vaccines against hepatitis b virus
|
|
CN108349982B
(zh)
|
2015-11-05 |
2020-05-05 |
正大天晴药业集团股份有限公司 |
作为tlr7激动剂的7-(噻唑-5-基)吡咯并嘧啶化合物
|
|
BR112018010172A2
(pt)
|
2015-11-19 |
2018-11-21 |
Bristol Myers Squibb Co |
anticorpos contra receptor de fator de necrose de tumor induzido por glicocorticoide (gitr) e usos dos mesmos
|
|
US20170145025A1
(en)
|
2015-11-19 |
2017-05-25 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
CR20180286A
(es)
|
2015-12-03 |
2018-07-16 |
Glaxosmithkline Ip Dev Ltd |
Dinucleotidos de purina cíclicos como moduladores de sting
|
|
EP3386512B1
(en)
|
2015-12-10 |
2023-11-22 |
Merck Sharp & Dohme LLC |
Antiviral phosphodiamide prodrugs of tenofovir
|
|
WO2017106740A1
(en)
|
2015-12-16 |
2017-06-22 |
Aduro Biotech, Inc. |
Methods for identifying inhibitors of "stimulator of interferon gene"-dependent interferon production
|
|
EP3390361B1
(en)
|
2015-12-17 |
2022-03-16 |
Incyte Corporation |
N-phenyl-pyridine-2-carboxamide derivatives and their use as pd-1/pd-l1 protein/protein interaction modulators
|
|
RS65319B1
(sr)
|
2015-12-17 |
2024-04-30 |
Merck Patent Gmbh |
8-cijano-5-piperidino-hinolini kao tlr7/8 antagonisti i njihova upotreba u lečenju imunoloških poremećaja
|
|
LT3394033T
(lt)
|
2015-12-22 |
2021-03-10 |
Incyte Corporation |
Heterocikliniai junginiai, kaip imunomoduliatoriai
|
|
ES2901000T3
(es)
*
|
2015-12-23 |
2022-03-21 |
Prec Biosciences Inc |
Meganucleasas de ingeniería con secuencias de reconocimiento encontradas en el gen de la microglobulina beta-2 humana
|
|
US9845325B2
(en)
|
2016-02-19 |
2017-12-19 |
Novartis Ag |
Tetracyclic pyridone compounds as antivirals
|
|
CN109475570B
(zh)
|
2016-03-18 |
2022-04-01 |
免疫传感器公司 |
环二核苷酸化合物及使用方法
|
|
CA3018537C
(en)
|
2016-03-21 |
2025-04-22 |
Council Of Scientific & Industrial Research |
Signal blocking by TLR9 (Toll-like receiver 9) with a small molecule antagonist
|
|
US10358463B2
(en)
|
2016-04-05 |
2019-07-23 |
Bristol-Myers Squibb Company |
Immunomodulators
|
|
SG11201809082WA
(en)
|
2016-04-19 |
2018-11-29 |
Innate Tumor Immunity Inc |
Nlrp3 modulators
|
|
US10533007B2
(en)
|
2016-04-19 |
2020-01-14 |
Innate Tumor Immunity, Inc. |
NLRP3 modulators
|
|
EP3448393A1
(en)
|
2016-04-25 |
2019-03-06 |
Invivogen |
Novel complexes of immunostimulatory compounds, and uses thereof
|
|
DK3452583T3
(da)
|
2016-05-03 |
2022-01-10 |
Prec Biosciences Inc |
Konstruerede nukleaser, der er nyttige til behandling af hæmofili a
|
|
SG11201809859VA
(en)
|
2016-05-06 |
2018-12-28 |
Shanghai De Novo Pharmatech Co Ltd |
Benzazepine derivative, preparation method, pharmaceutical composition and use thereof
|
|
US20170320875A1
(en)
|
2016-05-06 |
2017-11-09 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
EP3458455B1
(en)
|
2016-05-20 |
2021-06-16 |
F. Hoffmann-La Roche AG |
Novel pyrazine compounds with oxygen, sulfur and nitrogen linker for the treatment of infectious diseases
|
|
JP7022702B2
(ja)
|
2016-05-23 |
2022-02-18 |
エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト |
第二級アミド基を有するベンズアゼピンジカルボキサミド化合物
|
|
CN109153648B
(zh)
|
2016-05-23 |
2022-07-22 |
豪夫迈·罗氏有限公司 |
具有叔酰胺官能团的苯并氮杂卓二甲酰胺化合物
|
|
JP6957522B2
(ja)
|
2016-05-26 |
2021-11-02 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
Ｂ型肝炎ウイルス疾患の治療および予防のためのキサントン誘導体
|
|
US20170342060A1
(en)
|
2016-05-26 |
2017-11-30 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
WO2017211791A1
(en)
|
2016-06-07 |
2017-12-14 |
F. Hoffmann-La Roche Ag |
Combination therapy of an hbsag inhibitor and a tlr7 agonist
|
|
EP3468561A4
(en)
|
2016-06-10 |
2019-12-04 |
Enanta Pharmaceuticals, Inc. |
ANTIVIRAL AGENTS AGAINST HEPATITIS B
|
|
EP3468963B1
(en)
|
2016-06-12 |
2021-10-27 |
F. Hoffmann-La Roche AG |
Dihydropyrimidinyl benzazepine carboxamide compounds
|
|
WO2017216686A1
(en)
|
2016-06-16 |
2017-12-21 |
Novartis Ag |
8,9-fused 2-oxo-6,7-dihydropyrido-isoquinoline compounds as antivirals
|
|
WO2017216685A1
(en)
|
2016-06-16 |
2017-12-21 |
Novartis Ag |
Pentacyclic pyridone compounds as antivirals
|
|
HRP20221030T1
(hr)
|
2016-06-20 |
2022-11-11 |
Incyte Corporation |
Heterociklički spojevi kao imunomodulatori
|
|
CN108290893B
(zh)
|
2016-06-22 |
2021-01-05 |
四川科伦博泰生物医药股份有限公司 |
二氢蝶啶酮类衍生物、其制备方法及其用途
|
|
MA45550A
(fr)
|
2016-06-29 |
2019-05-08 |
Novira Therapeutics Inc |
Dérivés de diazépinone et leur utilisation dans le traitement des infections par l'hépatite b
|
|
CN109415367B
(zh)
|
2016-06-29 |
2021-04-16 |
豪夫迈·罗氏有限公司 |
用于治疗和预防乙型肝炎病毒感染的新的二氢吡咯并嘧啶类化合物
|
|
CN109311880B
(zh)
|
2016-06-29 |
2021-09-03 |
豪夫迈·罗氏有限公司 |
用于治疗和预防乙型肝炎病毒感染的新的四氢吡啶并嘧啶类化合物
|
|
US10071079B2
(en)
|
2016-06-29 |
2018-09-11 |
Bristol-Myers Squibb Company |
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
|
|
US10987359B2
(en)
|
2016-06-29 |
2021-04-27 |
Novira Therapeutics, Inc. |
Oxadiazepinone derivatives and methods of treating hepatitis B infections
|
|
KR102468272B1
(ko)
|
2016-06-30 |
2022-11-18 |
삼성전자주식회사 |
음향 출력 장치 및 그 제어 방법
|
|
CN109476675B
(zh)
|
2016-07-01 |
2022-12-09 |
爱尔兰詹森科学公司 |
用于治疗病毒性感染的二氢吡喃并嘧啶衍生物
|
|
WO2018009466A1
(en)
|
2016-07-05 |
2018-01-11 |
Aduro Biotech, Inc. |
Locked nucleic acid cyclic dinucleotide compounds and uses thereof
|
|
ES2895066T3
(es)
|
2016-07-08 |
2022-02-17 |
Bristol Myers Squibb Co |
Derivados de 1,3-dihidroxi-fenilo útiles como inmunomoduladores
|
|
WO2018011160A1
(en)
|
2016-07-14 |
2018-01-18 |
F. Hoffmann-La Roche Ag |
6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine compounds for the treatment of infectious diseases
|
|
EP3484886B1
(en)
|
2016-07-14 |
2020-03-04 |
Hoffmann-La Roche AG |
6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine and 6,7-dihydro-4h-triazolo[1,5-a]pyrazine compounds for the treatment of infectious diseases
|
|
EP3484883B1
(en)
|
2016-07-14 |
2020-04-15 |
H. Hoffnabb-La Roche Ag |
Novel tetrahydropyrazolopyridine compounds for the treatment of infectious diseases
|
|
WO2018013789A1
(en)
|
2016-07-14 |
2018-01-18 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
WO2018011162A1
(en)
|
2016-07-14 |
2018-01-18 |
F. Hoffmann-La Roche Ag |
Carboxy 6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine compounds for the treatment of infectious diseases
|
|
WO2018019297A1
(zh)
|
2016-07-29 |
2018-02-01 |
银杏树药业(苏州)有限公司 |
异喹啉酮类化合物及其制备抗病毒药物的应用
|
|
CN110240596B
(zh)
|
2016-07-29 |
2020-09-11 |
新波制药有限公司 |
用于治疗hbv感染的治疗剂
|
|
EP3490983B1
(en)
|
2016-07-30 |
2021-02-17 |
Bristol-Myers Squibb Company |
Dimethoxyphenyl substituted indole compounds as tlr7, tlr8 or tlr9 inhibitors
|
|
WO2018026971A1
(en)
|
2016-08-03 |
2018-02-08 |
Arising International, Llc |
Symmetric or semi-symmetric compounds useful as immunomodulators
|
|
MX390698B
(es)
|
2016-08-08 |
2025-03-11 |
Merck Patent Gmbh |
Antagonistas del receptor 7/8 tipo toll (tlr7/8) y uso de los mismos.
|
|
EP3503894A1
(en)
|
2016-08-24 |
2019-07-03 |
H. Hoffnabb-La Roche Ag |
Combination therapy of an hbv capsid assembly inhibitor and a nucleos(t)ide analogue
|
|
WO2018038877A1
(en)
|
2016-08-26 |
2018-03-01 |
3M Innovative Properties Company |
FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS SUBSTITUTED WITH GUANIDINO GROUPS
|
|
MA46045A
(fr)
|
2016-08-29 |
2021-04-28 |
Incyte Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
|
US10144706B2
(en)
|
2016-09-01 |
2018-12-04 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
|
US10640499B2
(en)
|
2016-09-02 |
2020-05-05 |
Gilead Sciences, Inc. |
Toll like receptor modulator compounds
|
|
US10370342B2
(en)
|
2016-09-02 |
2019-08-06 |
Gilead Sciences, Inc. |
Toll like receptor modulator compounds
|
|
WO2018043747A1
(ja)
|
2016-09-05 |
2018-03-08 |
国立大学法人京都大学 |
抗ｂ型肝炎ウイルス剤
|
|
WO2018046460A1
(en)
|
2016-09-07 |
2018-03-15 |
Glaxosmithkline Biologicals S.A. |
Imidazoquinoline derivatives and their use in therapy
|
|
HRP20220144T1
(hr)
|
2016-09-09 |
2022-04-15 |
Novartis Ag |
Spojevi i pripravci kao inhibitori endosomskih toll-u sličnih receptora
|
|
US10660877B2
(en)
|
2016-09-09 |
2020-05-26 |
Bristol-Myers Squibb Company |
Pyridyl substituted indole compounds
|
|
CN109803967B
(zh)
|
2016-09-09 |
2022-05-24 |
浙江海正药业股份有限公司 |
二氢嘧啶类化合物及其制备方法和用途
|
|
WO2018051254A1
(en)
|
2016-09-14 |
2018-03-22 |
Aurigene Discovery Technologies Limited |
Cyclic substituted-1,2,4-oxadiazole compounds as immunomodulators
|
|
WO2018051255A1
(en)
|
2016-09-14 |
2018-03-22 |
Aurigene Discovery Technologies Limited |
Cyclic substituted-1,3,4-oxadiazole and thiadiazole compounds as immunomodulators
|
|
US10537590B2
(en)
|
2016-09-30 |
2020-01-21 |
Boehringer Ingelheim International Gmbh |
Cyclic dinucleotide compounds
|
|
GEP20217285B
(en)
|
2016-10-04 |
2021-08-10 |
Merck Sharp & Dohme |
BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS
|
|
EP3523314A1
(de)
|
2016-10-07 |
2019-08-14 |
Biolog Life Science Institute Forschungslabor Und Biochemica-Vertrieb GmbH |
Benzimidazolhaltige cyclische dinukleotide, verfahren zu deren herstellung und ihre verwendung zur aktivierung von stimulator von interferongenen (sting)-abhängigen signalwegen
|
|
PE20191353A1
(es)
|
2016-10-14 |
2019-10-01 |
Prec Biosciences Inc |
Meganucleasas disenadas especificamente para el reconocimiento de secuencias en el genoma del virus de la hepatitis b
|
|
KR20190067235A
(ko)
|
2016-10-20 |
2019-06-14 |
오리진 디스커버리 테크놀로지스 리미티드 |
Vista 및 pd-1 경로의 이중 억제제
|
|
US10736908B2
(en)
|
2016-10-26 |
2020-08-11 |
Merck Sharp & Dohme Corp. |
Antiviral aryl-amide phosphodiamide compounds
|
|
WO2018078149A1
(en)
|
2016-10-31 |
2018-05-03 |
F. Hoffmann-La Roche Ag |
Novel cyclicsulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection
|
|
KR102526034B1
(ko)
|
2016-11-07 |
2023-04-25 |
브리스톨-마이어스 스큅 컴퍼니 |
면역조정제
|
|
US11084818B2
(en)
|
2016-11-11 |
2021-08-10 |
Hepo Pharmaceutical Co., Ltd. |
Nitrogen-containing heterocyclic compound, preparation method, intermediate, pharmaceutical composition and use
|
|
WO2018089695A1
(en)
|
2016-11-11 |
2018-05-17 |
Dynavax Technologies Corporation |
Toll-like receptor antagonist compounds and methods of use
|
|
JOP20170188A1
(ar)
|
2016-11-25 |
2019-01-30 |
Janssen Biotech Inc |
ثنائي النوكليوتيدات الحلقية كمنبهات ستينغ (sting)
|
|
MY192084A
(en)
|
2016-11-28 |
2022-07-26 |
Jiangsu Hengrui Medicine Co |
Pyrazolo-heteroaryl derivative, preparation method and medical use thereof
|
|
JOP20170192A1
(ar)
|
2016-12-01 |
2019-01-30 |
Takeda Pharmaceuticals Co |
داي نوكليوتيد حلقي
|
|
KR102599339B1
(ko)
|
2016-12-20 |
2023-11-08 |
브리스톨-마이어스 스큅 컴퍼니 |
면역조정제로서 유용한 화합물
|
|
WO2018118665A1
(en)
|
2016-12-20 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Cyclic dinucleotide sting agonists for cancer treatment
|
|
AU2017378782A1
(en)
|
2016-12-20 |
2019-07-04 |
Merck Sharp & Dohme Corp. |
Combinations of PD-1 antagonists and cyclic dinucleotide sting agonists for cancer treatment
|
|
MA47094A
(fr)
|
2016-12-22 |
2021-05-26 |
Idenix Pharmaceuticals Llc |
Promédicaments d'ester aliphatique antiviral de ténofovir
|
|
WO2018119221A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Pyridine derivatives as immunomodulators
|
|
BR112019012511A2
(pt)
|
2016-12-22 |
2019-11-19 |
Idenix Pharmaceuticals Llc |
compostos antivirais de benzil-amina fosfodiamida, composição farmacêutica e uso do composto
|
|
EP3558963B1
(en)
|
2016-12-22 |
2022-03-23 |
Incyte Corporation |
Bicyclic heteroaromatic compounds as immunomodulators
|
|
BR112019012993A2
(pt)
|
2016-12-22 |
2019-12-03 |
Incyte Corporation |
derivados de benzo-oxazol como imunomoduladores
|
|
WO2018119236A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Triazolo[1,5-a]pyridine derivatives as immunomodulators
|
|
US20180177784A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
JPWO2018199338A1
(ja)
|
2017-04-27 |
2020-03-12 |
国立大学法人広島大学 |
Ｂ型肝炎治療用核酸分子
|
|
US11142750B2
(en)
|
2018-04-12 |
2021-10-12 |
Precision Biosciences, Inc. |
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
|